EPG Online Twitter 
EPG Online Blog 
Disease Knowledge Drug Updates
Cancer patients receiving drugs to lower the risk of anaemia may be...
Published Tuesday 01 December 2009
Chemotherapy can result in insomnia
Insomnia occurs in approximately three-quarters of cancer patients who have undergone chemotherapy....
Published Tuesday 01 December 2009
Osteoarthritis risk increased by high exercise levels
Men and women in middle age who exercise on a regular basis...
Published Monday 30 November 2009
Cancer genome changes increase cervical cancer relapse risk
Patients with cervical cancer are three to four times more likely to...
Published Sunday 29 November 2009
Number of Americans with diabetes expected to double by 2034
The number of people developing diabetes in the US is expected to...
Published Sunday 29 November 2009
H1N1 virus appears to increase asthma risk in children
Asthma is a significant risk factor in children who have contracted the...
Published Sunday 29 November 2009
New treatment could prevent thrombosis in PAD patients
Thrombosis is a common side effect in patients undergoing bypass surgery for...
Published Sunday 29 November 2009
More Medical News
Alzheimer's biomarker could help ensure treatment starts earlier
19 Jun 2009 - Posted by the Editorial Team
Research conducted at the Sahlgrenska Academy, Sweden, suggests it is possible to detect Alzheimer's disease earlier than previously thought.
A study which appears in the medical journal Lancet Neurology shows it is possible to spot a biomarker known as the CSF AD profile, which can be used as an indicator of Alzheimer's, in the cerebrospinal fluid before other tests can confirm an accurate diagnosis.
According to Kaj Blennow, a professor at the Sahlgrenska Academy, the discovery has important implications for Alzheimer's treatment.
"The earlier we can catch Alzheimer's disease, the more we can do for the patient," he commented.
"The disease is one that progresses slowly, and the pharmaceuticals that are currently available are only able to alleviate the symptoms."
Professor Blennow added that it is of vital importance that treatment is started before changes to the brain become too severe.
Statistics released by the National Institute of Aging show symptoms of Alzheimer's usually appear in patients after they have reached the age of 60.
Login and visit the Alzheimer's Disease Knowledge Centre
Print Article 
Bookmark
- Alzheimer's treatments needed urgently, expert says 17/11/09
- Importance of biomarkers in Alzheimer's disease fight 11/11/09
- Frontotemporal dementia is hereditary, researchers discover 03/11/09
- Neurodegenerative disease could be treated with anti-epilepsy drugs 28/10/09
- Heart attack symptoms similar in men and women, study discovers 27/10/09
- Dyloject® 75 mg/2 ml Solution for Injection
- COZAAR® 2.5 mg/ml powder and solvent for oral suspension
- Fluvastatin 20mg Capsules
- Fluvastatin 40mg Capsules
- Tegretol® Retard 200mg and 400mg Tablets
- Seretide 50, 125, 250 Evohaler
- Thymoglobuline®25 mg powder for solution for infusion
- Tegretol® 100mg/5ml Liquid
- Tegretol® 125mg, 250 mg Suppositories
- Synflorix suspension for injection in pre-filled syringe
- Timodine
- Clarithromycin Film-coated Tablets
